0 (0%) | 03-29 00:58 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 71.61 | 1-year : | 83.64 |
Resists | First : | 61.31 | Second : | 71.61 |
Pivot price | 58.79 | |||
Supports | First : | 58.12 | Second : | 56.15 |
MAs | MA(5) : | 59.71 | MA(20) : | 58.61 |
MA(100) : | 55.62 | MA(250) : | 52.66 | |
MACD | MACD : | 1 | Signal : | 0.9 |
%K %D | K(14,3) : | 85 | D(3) : | 81.8 |
RSI | RSI(14): 76.5 | |||
52-week | High : | 61.31 | Low : | 45.1 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ DTM ] has closed above the upper band by 15.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 9.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 61.39 - 61.64 | 61.64 - 61.87 |
Low: | 58.89 - 59.16 | 59.16 - 59.42 |
Close: | 60.66 - 61.09 | 61.09 - 61.5 |
Mon, 26 Feb 2024
Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie ... - GlobeNewswire
Wed, 31 May 2023
B-Cell Lymphoma Clinical Trial Pipeline Insights: DelveInsight Evaluates a Robust Pipeline as 160+ Influential Pharma ... - GlobeNewswire
Fri, 27 Jan 2023
Advanced digital mapping solution for Czech railway infrastructure - GIM International
Tue, 17 Jan 2023
Hexagon and Ness provide digital maps for Czech Railways - GPS World magazine
Mon, 20 Jun 2022
Page 12 - NAVAL FORCES 02/2017 - Document
Fri, 16 Jul 2021
Standard Missile-6 - Naval Technology
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 97 (M) |
Shares Float | 97 (M) |
Held by Insiders | 0.2 (%) |
Held by Institutions | 84.5 (%) |
Shares Short | 2,810 (K) |
Shares Short P.Month | 2,780 (K) |
EPS | 3.94 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 42.68 |
Profit Margin | 41.6 % |
Operating Margin | 49.1 % |
Return on Assets (ttm) | 3.2 % |
Return on Equity (ttm) | 9.3 % |
Qtrly Rev. Growth | 0.4 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 9.5 |
EBITDA (p.s.) | 6.69 |
Qtrly Earnings Growth | 42.2 % |
Operating Cash Flow | 798 (M) |
Levered Free Cash Flow | -381 (M) |
PE Ratio | 15.5 |
PEG Ratio | 4.1 |
Price to Book value | 1.43 |
Price to Sales | 6.42 |
Price to Cash Flow | 7.42 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |